TrialMedical oncology (Northwood, London, England)2015

Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study.

Roberto Petrioli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.